GGrantIndex
← Search

MORPHOLINOBENZAMIDES AS POTENT ANTITUBERCULAR AGENTS TARGETING MYCOBACTERIAL RESPIRATION

$2,089,182FY2020Defense Health AgencyDOD

Seattle Children'S Hospital, Seattle WA

Investigators

View source on USAspending →
MORPHOLINOBENZAMIDES AS POTENT ANTITUBERCULAR AGENTS TARGETING MYCOBACTERIAL RESPIRATION · GrantIndex